Hostname: page-component-848d4c4894-5nwft Total loading time: 0 Render date: 2024-05-08T12:09:23.859Z Has data issue: false hasContentIssue false
  • English
  • Français

Amyloid Myoneuropathy Mimicking Inclusion Body Myositis

Published online by Cambridge University Press:  23 September 2014

Ahmad R. Abuzinadah ,
Jeffrey T. Joseph  and
Lawrence Korngut
Ahmad R. Abuzinadah
Affiliation:
Department of Clinical Neuroscience, University of Calgary, South Health Campus, Calgary, Alberta, Canada
Jeffrey T. Joseph
Affiliation:
Hotchkiss Brain Institute, Department of Pathology, University of Calgary, South Health Campus, Calgary, Alberta, Canada
Lawrence Korngut*
Affiliation:
Department of Clinical Neuroscience, University of Calgary, South Health Campus, Calgary, Alberta, Canada
*
4th Floor Administration, Clinical Neurosciences, South Health Campus, 4448 Front Street S.E., Calgary, Alberta, T3M 1M4, Canada. Email: korngut@gmail.com.
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Brief Communications
Information
Canadian Journal of Neurological Sciences , Volume 40 , Issue 2 , March 2013 , pp. 255 - 258
Copyright
Copyright © The Canadian Journal of Neurological 2013

References

1. Dalakas, MC, Illa, I, Gallardo, E, Juarez, C. Inclusion body myositis and paraproteinemia: incidence and immunopathologic correlations. Ann Neurol. 1997;41(1):100–4.CrossRefGoogle ScholarPubMed
2. Matsuda, M, Gono, T, Morita, H, Katoh, N, Kodaira, M, Ikeda, S. Peripheral nerve involvement in primary systemic AL amyloidosis: a clinical and electrophysiological study. Eur J Neurol. 2011;18(4):604–10.CrossRefGoogle ScholarPubMed
3. Chapin, JE, Kornfeld, M, Harris, A. Amyloid myopathy: Characteristic features of a still underdiagnosed disease. Muscle Nerve. 2005;31(2):266–72.Google Scholar
4. Rubin, DI, Hermann, RC. Electrophysiologic findings in amyloid myopathy. Muscle Nerve. 1999;22(3):355–9.Google Scholar
5. Venner, CP, Lane, T, Foard, D, et al. Cyclophosphamide, bortezomib, and dexamethasone therapy in AL amyloidosis is associated with high clonal response rates and prolonged progression-free survival. Blood. 2012;119(19):4387–90.CrossRefGoogle ScholarPubMed
6. Hermanns, B, Molnar, M, Schröder, JM. Peripheral neuropathy associated with hereditary and sporadic inclusion body myositis: confirmation by electron microscopy and morphometry. J Neurol Sci. 2000;179(1-2):92–102.CrossRefGoogle ScholarPubMed
7. Schoser, B. Physiology, pathophysiology and diagnostic significance of autopahgic changes in skeletal muscle tissue - towards the enigma of rimmed and round vacules. Clin Neuropathol. 2009;28(1):59–70.Google Scholar
8. Limaye, V, Blumbergs, P. The prevalence of rimmed vacuoles in biopsy-proven dermatomyositis. Muscle Nerve. 2010;41(2): 288–9.CrossRefGoogle ScholarPubMed
9. Bruni, J, Bilbao, JM, Pritzker, PH. Myopathy associated with amyloid angiopathy. Can J Neurol Sci. 1977;4(1):77–80.CrossRefGoogle ScholarPubMed
10. Roke, ME, Brown, WF, Boughner, D, Ang, LC, Rice, GP. Myopathy in primary systemic amyloidosis. Can J Neurol Sci. 1988;15(3): 314–6.CrossRefGoogle ScholarPubMed
11. Keith, J, Afshar-Ghotli, Z, Roussev, R, Ernst, B, Young, B, Bilbao, J. Myopathy as the Initial Manifestation of Primary Amyloidosis. Can J Neurol Sci. 2011;38(1):161–4.Google Scholar
12. Tuomaala, H, Kärppä, M, Tuominen, H, Remes, AM. Amyloid myopathy: a diagnostic challenge. Neurol Int. 2009;1(e7):24–6.Google Scholar
13. Kyle, RA, Therneau, TM, Rajkumar, SV, et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med. 2002;346(8):564–9.CrossRefGoogle ScholarPubMed